help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-1587
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
147/8/3906    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steinberg, G. R.
Right arrow Articles by Kemp, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steinberg, G. R.
Right arrow Articles by Kemp, B. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Substance via MeSH
Medline Plus Health Information
*Nutrition
*Obesity
Endocrinology Vol. 147, No. 8 3906-3914
Copyright © 2006 by The Endocrine Society

Ciliary Neurotrophic Factor Suppresses Hypothalamic AMP-Kinase Signaling in Leptin-Resistant Obese Mice

Gregory R. Steinberg, Matthew J. Watt, Barbara C. Fam, Joseph Proietto, Sofianos Andrikopoulos, Andrew M. Allen, Mark A. Febbraio and Bruce E. Kemp

St. Vincent’s Institute (G.R.S., B.E.K.) and Department of Medicine (G.R.S., B.E.K.), St. Vincent’s Hospital, Fitzroy 3065, Australia; Department of Medicine (B.C.F., J.P., S.A.), Heidelberg Repatriation Hospital, 3081 Heidelberg, Germany; Department of Physiology (A.M.A.), University of Melbourne, and Commonwealth Scientific and Industrial Research Organization Molecular and Health Technologies (B.E.K.), Parkville 3052, Australia; and Cellular and Molecular Metabolism Laboratory (M.J.W., M.A.F.), School of Medical Sciences, Royal Melbourne Institute of Technology, Bundoora, Victoria 3083, Australia

Address all correspondence and requests for reprints to: Gregory R. Steinberg, St. Vincent’s Institute, 9 Princes Street, Fitzroy, Victoria 3065, Australia. E-mail: gsteinberg{at}svi.edu.au.

We examined the actions of a second-generation ciliary neurotrophic factor analog (CNTFAx15) on AMP-activated protein kinase (AMPK), a known regulator of food intake. Unlike leptin CNTFAx15 has been shown to reduce food intake in obese rodents and humans. Intraperitoneal injection of CNTFAx15 acutely (45 min) reduced hypothalamic AMPK{alpha}2 activity, AMPK{alpha}2Thr172 phosphorylation, and acetyl-coenzyme A carboxylase phosphorylation, effects not observed 2 or 6 h after injection. Intracerebroventricular CNTFAx15 reduced food intake, increased arcuate nucleus (ARC) signal transducer and activator of transcription 3 phosphorylation, and reduced AMPK signaling but not in the paraventricular nucleus (PVN), posterior hypothalamus, or cortex. To compare the effects of leptin and CNTFAx15 in a diet-induced model of obesity, mice were fed a control carbohydrate or high-fat diet (HFD) for 12 wk. Leptin treatment ip reduced food intake in control mice but not in mice fed a HFD. In contrast, ip CNTF markedly reduced food intake in both control and HFD animals. Both leptin and CNTF reduced AMPK activity and acetyl-coenzyme A carboxylase phosphorylation in the ARC and PVN of control-fed mice. A HFD blunted leptin but not CNTF effects on AMPK signaling in the ARC and PVN. In summary, these data demonstrate that CNTFAx15 bypasses diet-induced leptin resistance to reduce hypothalamic AMPK activity.




This article has been cited by other articles:


Home page
J EndocrinolHome page
L. F Rezende, L. F Stoppiglia, K. L A Souza, A. Negro, F. Langone, and A. C Boschero
Ciliary neurotrophic factor promotes survival of neonatal rat islets via the BCL-2 anti-apoptotic pathway
J. Endocrinol., October 1, 2007; 195(1): 157 - 165.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
N. Simler, A. Malgoyre, N. Koulmann, A. Alonso, A. Peinnequin, and A. X. Bigard
Hypoxic stimulus alters hypothalamic AMP-activated protein kinase phosphorylation concomitant to hypophagia
J Appl Physiol, June 1, 2007; 102(6): 2135 - 2141.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
F. Cai, A. V Gyulkhandanyan, M. B Wheeler, and D. D Belsham
Glucose regulates AMP-activated protein kinase activity and gene expression in clonal, hypothalamic neurons expressing proopiomelanocortin: additive effects of leptin or insulin
J. Endocrinol., March 1, 2007; 192(3): 605 - 614.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. L. Carey, G. R. Steinberg, S. L. Macaulay, W. G. Thomas, A. G. Holmes, G. Ramm, O. Prelovsek, C. Hohnen-Behrens, M. J. Watt, D. E. James, et al.
Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase.
Diabetes, October 1, 2006; 55(10): 2688 - 2697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society